Back to Search Start Over

Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)

Authors :
Sang-Jae Park
Taesung Park
Yoo Seok Yoon
Hee Joon Kim
Wooil Kwon
Jin Seok Heo
Young Hoon Roh
Seung Eun Lee
Yong Hoon Kim
Seong-Ryong Kim
J.I. Moon
Dae Wook Hwang
Hongbeom Kim
Joon Seong Park
Jae Seung Kang
Jae Do Yang
Il Young Park
Seungyeoun Lee
Sang Hyun Shin
Huisong Lee
Jae Hoon Lee
Sang Kuon Lee
Chi-Young Jeong
Chang-Sup Lim
Ho-Seong Han
Young-Dong Yu
Woo Jung Lee
Lydia Mok
In Woong Han
Jin-Young Jang
Source :
Gut and Liver
Publication Year :
2021
Publisher :
Editorial Office of Gut and Liver, 2021.

Abstract

Background/aims Several prediction models for evaluating the prognosis of nonmetastatic resected pancreatic ductal adenocarcinoma (PDAC) have been developed, and their performances were reported to be superior to that of the 8th edition of the American Joint Committee on Cancer (AJCC) staging system. We developed a prediction model to evaluate the prognosis of resected PDAC and externally validated it with data from a nationwide Korean database. Methods Data from the Surveillance, Epidemiology and End Results (SEER) database were utilized for model development, and data from the Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP) database were used for external validation. Potential candidate variables for model development were age, sex, histologic differentiation, tumor location, adjuvant chemotherapy, and the AJCC 8th staging system T and N stages. For external validation, the concordance index (C-index) and time-dependent area under the receiver operating characteristic curve (AUC) were evaluated. Results Between 2004 and 2016, data from 9,624 patients were utilized for model development, and data from 3,282 patients were used for external validation. In the multivariate Cox proportional hazard model, age, sex, tumor location, T and N stages, histologic differentiation, and adjuvant chemotherapy were independent prognostic factors for resected PDAC. After an exhaustive search and 10-fold cross validation, the best model was finally developed, which included all prognostic variables. The C-index, 1-year, 2-year, 3-year, and 5-year time-dependent AUCs were 0.628, 0.650, 0.665, 0.675, and 0.686, respectively. Conclusions The survival prediction model for resected PDAC could provide quantitative survival probabilities with reliable performance. External validation studies with other nationwide databases are needed to evaluate the performance of this model.

Details

Language :
English
ISSN :
20051212 and 19762283
Volume :
15
Issue :
6
Database :
OpenAIRE
Journal :
Gut and Liver
Accession number :
edsair.doi.dedup.....d5b0cff869216f9edc6624521c4f51d6